Search

everythinglearnresearchcommunity

for

Search:↓

Six new risk spots for early hair loss were found, which also link to Parkinson's disease and lower fertility. Two genes, FOXA2 and HDAC4, could be new treatment targets. Hair loss might also be connected to heart disease, metabolic syndrome, and prostate cancer.

The engineered yeast strain BLYAS can quickly and sensitively detect androgenic chemicals.

Inhibitors of the enzyme 5 alpha-reductase could potentially treat disorders like prostate cancer and baldness.

Androgens are important for female fertility and could help in IVF treatment, but also play a role in causing PCOS.

Mouse genital development depends on male or female hormones for specific features.

Understanding how DHT works is important for diagnosing and treating hormone-related disorders.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

Testosterone may influence COVID-19 severity and outcomes.

Five preservatives may disrupt hormone function and need more health and environmental risk assessment.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

Testosterone can slow hair growth in adult monkeys, but a blocker called RU 58841 can counteract this and potentially help hair regrow.

A mushroom extract might reduce hair loss and liver damage caused by certain chemotherapy drugs in animals.

Polycystic ovary syndrome increases the risk of diabetes, heart disease, and endometrial cancer, and requires early treatment to manage these risks.

Prostate cancer can progress even with low testosterone due to internal hormone production in the tumor.

Mice without the enzyme HSD17B3 still produce normal testosterone, suggesting they have different ways to make it compared to humans.

Androgens and a high-fat diet may increase the risk of severe COVID-19 in women with PCOS by upregulating certain proteins in the heart and kidneys.

The secretome from mesenchymal stromal cells shows promise for improving facial nerve injury treatment.

A specific pathway involving AR, miR-221, and IGF-1 plays a key role in causing common hair loss.

A new, efficient method has been developed to detect darolutamide and thalidomide, drugs used for certain hair loss and prostate cancer treatments, in pharmaceuticals and body fluids.

Understanding hair growth involves complex factors, and more research is needed to improve treatments for hair loss conditions.

A 68-year-old woman developed male traits due to a tumor in her ovary, which was removed, returning her hormone levels to normal.

Hair loss in androgenetic alopecia may be due to ongoing tiny inflammation and tissue changes around hair follicles.

Hair RiseTM microemulsion effectively promotes hair growth and treats hair loss better than standard treatments.

Personalized treatments for hair loss are becoming more effective by using genetic information.

Scientists created cell lines from balding patients and found that cells from the front of the scalp are more affected by hormones that cause hair loss than those from the back.

Polycystic ovary syndrome causes high male hormone levels, leading to symptoms like excess hair, acne, and fertility problems.

Scientists have improved 3D models of human skin for research and medical uses, but still face challenges in perfectly replicating real skin.

New treatments for hair loss should target eight main causes and use specific plant compounds and peptides for better results.

Protein tyrosine kinases are key in male pattern baldness, affecting skin structure, hair growth, and immune responses.

Polycystic Ovary Syndrome (PCOS) is a common but often undiagnosed disorder in women that can cause irregular periods, infertility, and other symptoms, and can be managed with lifestyle changes, medication, and sometimes surgery.